Patients ‘tolerate arbaclofen extended-release tabs’
Patients ‘tolerate arbaclofen extended-release tabs’
Arbaclofen extended-release tablets (AERT) have proved to have greater tolerability, and similar efficacy and safety, to baclofen in patients with multiple sclerosis (MS), according to randomised trial results reported at the 68th American Academy of Neurology annual Meeting...Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/